Previous Close | 138.15 |
Open | 137.82 |
Bid | 137.25 x 900 |
Ask | 138.23 x 900 |
Day's Range | 132.96 - 138.95 |
52 Week Range | 127.02 - 191.75 |
Volume | |
Avg. Volume | 1,391,542 |
Market Cap | 16.992B |
Beta (5Y Monthly) | 0.21 |
PE Ratio (TTM) | 39.89 |
EPS (TTM) | 3.47 |
Earnings Date | Apr 28, 2022 - May 02, 2022 |
Forward Dividend & Yield | 4.64 (2.93%) |
Ex-Dividend Date | Apr 26, 2022 |
1y Target Est | 137.93 |
I'm a big fan of great companies when investors aren't showing them much love. These two dividend stocks are squarely in that boat today.
The dollar is on a roll, thanks to the surge in U.S. interest rates, a strong U.S. economy and the war in Ukraine. The rise in rates helps the greenback because they make dollar-denominated fixed-income instruments more attractive.
In the current market evironment, investors could find solid ground with this dividend stocks to buy. Merck (MRK): Robust results across its core portfolio, with its oncology portfolio expected to fire on all cylinders. Chevron (CVX): Cash flow generating machine, which will benefit immensely from rising oil prices. Clorox (CLX): Attractive income stock, which has seen dividends grow every year since 1977. Procter and Gamble (PG): Consistent performer that has been on a roll of late. AbbVie (ABB